Skip to content
Disclosery

EXANE DERIVATIVES: COST position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on COST, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,325 COST shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,325 shares
    Change vs previous 13F -580 shares

    0.92% of the 13F portfolio, value $1,593,438.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,905 shares
    Change vs previous 13F +300 shares

    0.63% of the 13F portfolio, value $2,248,670.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,605 shares
    Change vs previous 13F -1,520 shares

    0.5% of the 13F portfolio, value $2,046,588.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5,125 shares
    Change vs previous 13F +245 shares

    0.57% of the 13F portfolio, value $2,302,953.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,880 shares
    Change vs previous 13F +1,062 shares

    0.47% of the 13F portfolio, value $1,986,468.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,818 shares
    Change vs previous 13F +604 shares

    0.41% of the 13F portfolio, value $1,345,791.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,214 shares
    Change vs previous 13F -13 shares

    0.37% of the 13F portfolio, value $1,210,989.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3,227 shares
    Change vs previous 13F not available

    0.37% of the 13F portfolio, value $1,145,580.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).